Pharming Group's total assets for Q3 2025 were $403.57M, a decrease of -9.57% from the previous quarter. PHAR total liabilities were $178.15M for the fiscal quarter, a -13.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.